Home / Sources / Select Committees / Science and Technology Commit… / Research integrity
Select Committee · Science and Technology Committee (Commons)

Research integrity

Status: Closed Opened: 13 Sep 2017 Closed: 9 Sep 2019 2 reports
Inquiry scopeThis inquiry looked at trends and developments in fraud, misconduct and mistakes in research and the publication of research results. Research by Parliamentary Office of Science and Technology indicates the trend in misconduct/mistakes in publishing is still upwards. There has also been a so-called 'crisis in reproducibility' of research. The Committee continues the previous Committee's inquiry , taking forward the evidence it had received before the General Election.

Reports

2 reports

Oral evidence sessions

6 sessions

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date Session and witnesses Source
8 May 2018
Oral evidence session
No witnesses recorded 		View ↗
6 Mar 2018
Oral evidence session
No witnesses recorded 		View ↗
30 Jan 2018
Oral evidence session
No witnesses recorded 		View ↗
4 Dec 2017
Oral evidence session
No witnesses recorded 		View ↗
21 Nov 2017
Oral evidence session
No witnesses recorded 		View ↗
24 Oct 2017
Oral evidence session
No witnesses recorded 		View ↗

Correspondence

4 letters

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

PublishedDirectionLetter
5 Sep 2019 — Correspondence from Teresa Allen, Chief Executive, Health Research Authority, to the Chair of the Committee, regarding Research integrity: clinical trials transparency, 22 August 2019
1 Jul 2019 To committee Letter from the Minister of State for Universities, Science, Research and Innovation to the Chair on implementing the Committee’s recommendations to establish a National Research Integrity Committee, 25 June 2019
6 Feb 2019 — Correspondence from Professor Sir Jonathan Montgomery, Health Research Authority, regarding the PACE trial, 29 January 2019
14 Nov 2018 To committee Letter from Chief Executive, Public Health England, to the Chair regarding clinical trials, 30 October 2018